![]() |
Volumn 341, Issue 12, 2008, Pages 794-799
|
Synthesis and positive inotropic evaluation of 2-(4-(4-substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl-n-(4,5-dihydro-1-methyl[1,2,4] triazolo[4,3-a]quinolin-7-yl)-acetamides
|
Author keywords
1,4 Diazepane; 1,2,4 Triazolo 4,3 a quinolines; Positive inotropic activity; Stroke volume
|
Indexed keywords
2 (4 (4 (2 BROMOBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (2 CHLOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (2 FLUOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (2 METHOXYBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (2,6 DICHLOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (3 FLUOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (3,4 DICHLOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (3,4 DIMETHOXYBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (4 CHLOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (4 FLUOROBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (4 METHOXYBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 (4 METHYLBENZYLOXY) 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 (4 BENZYLOXY 3 METHOXYBENZYL) 1,4 DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
2 (4 BENZYLPIPERAZIN 1 YL) N (3,4 DIHYDRO 2(1H)QUINOLINON 6 YL)ACETAMIDE;
2 CHLORO N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE;
ACETAMIDE DERIVATIVE;
CARDIOTONIC AGENT;
LEVOSIMENDAN;
MILRINONE;
PIPERANOMETOZINE;
TOBORINONE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHRONOTROPISM;
COMPARATIVE STUDY;
CONCENTRATION (PARAMETERS);
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG SYNTHESIS;
HEART LEFT ATRIUM;
HEART STROKE VOLUME;
IN VITRO STUDY;
INOTROPISM;
NONHUMAN;
PRIORITY JOURNAL;
RABBIT;
ACETAMIDES;
ANIMALS;
CARDIOTONIC AGENTS;
HEART;
QUINOLINES;
RABBITS;
STROKE VOLUME;
|
EID: 57049100541
PISSN: 03656233
EISSN: 15214184
Source Type: Journal
DOI: 10.1002/ardp.200800132 Document Type: Article |
Times cited : (9)
|
References (15)
|